These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38180458)

  • 21. Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry.
    Tscharre M; Egger F; Machata M; Rohla M; Michael N; Neumayr M; Zweiker R; Hajos J; Adlbrecht C; Suppan M; Helmreich W; Eber B; Huber K; Weiss TW
    PLoS One; 2017; 12(6):e0179349. PubMed ID: 28632784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of dyspnea in patients treated with third-generation P2Y
    Zhang N; Xu W; Li O; Zhang B
    BMC Cardiovasc Disord; 2020 Mar; 20(1):140. PubMed ID: 32183711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention.
    Abraham NS; Yang EH; Noseworthy PA; Inselman J; Yao X; Herrin J; Sangaralingham LR; Ngufor C; Shah ND
    Aliment Pharmacol Ther; 2020 Aug; 52(4):646-654. PubMed ID: 32657466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Loading Doses With P2Y12-Receptor Antagonists in Patients Without Dual Antiplatelet Therapy Undergoing Elective Coronary Intervention.
    Piqueras-Flores J; Jurado-Román A; López-Lluva MT; Sánchez-Pérez I; Abellán-Huerta J; Lozano-Ruiz Poveda F
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):56-59. PubMed ID: 30383607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel.
    Algül E; Sunman H; Dural M; Guliyev İ; Aker M; Felekoğlu MA; Erat M; Tulmaç M; Açıkel S; Çimen T
    Turk J Med Sci; 2019 Oct; 49(5):1358-1365. PubMed ID: 31549494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of P2Y
    Gosling R; Yazdani M; Parviz Y; Hall IR; Grech ED; Gunn JP; Storey RF; Iqbal J
    Platelets; 2017 Dec; 28(8):767-773. PubMed ID: 28267384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Potent Oral P2Y
    Ma S; Li Z; Yu P; Song H; Jiang Z; Li Y; Han Y
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):199-208. PubMed ID: 32006144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ticagrelor and Central Sleep Apnea.
    Revol B; Jullian-Desayes I; Tamisier R; Puel V; Mallaret M; Joyeux-Faure M; Pépin JL
    J Am Coll Cardiol; 2018 May; 71(20):2378-2379. PubMed ID: 29773166
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial.
    Welsh RC; Sidhu RS; Cairns JA; Lavi S; Kedev S; Moreno R; Cantor WJ; Stankovic G; Meeks B; Yuan F; Džavík V; Jolly SS
    Can J Cardiol; 2019 Oct; 35(10):1377-1385. PubMed ID: 31492492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise end-tidal CO2 predicts central sleep apnea in patients with heart failure.
    Cundrle I; Somers VK; Johnson BD; Scott CG; Olson LJ
    Chest; 2015 Jun; 147(6):1566-1573. PubMed ID: 25742609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription patterns of P2Y12 inhibitors following revascularization in the United States: 2013-2018.
    Kumar A; Lutsey PL; St Peter WL; Schommer JC; Van't Hof JR; Rajpurohit A; Farley JF
    Clin Transl Sci; 2023 Oct; 16(10):1886-1897. PubMed ID: 37466284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes.
    Koshy AN; Giustino G; Sartori S; Hooda A; Feng Y; Snyder C; Dasgupta S; Kumar KR; Krishnamoorthy-Melarcode P; Sweeny J; Khera S; Serrao GW; Sharma R; Dangas G; Kini AS; Mehran R; Sharma SK
    EuroIntervention; 2023 Mar; 18(15):1244-1253. PubMed ID: 36660810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.
    Park DW; Kwon O; Jang JS; Yun SC; Park H; Kang DY; Ahn JM; Lee PH; Lee SW; Park SW; Choi SW; Lee SG; Yoon HJ; Ahn T; Kim MH; Nah DY; Lee SY; Chae JK; Park SJ;
    Circulation; 2019 Dec; 140(23):1865-1877. PubMed ID: 31553203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.
    Shahzad A; Khanna V; Kemp I; Shaw M; Mars C; Cooper R; Wilson K; Curzen N; Stables RH
    EuroIntervention; 2018 Mar; 13(16):1931-1938. PubMed ID: 29336311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation is associated with central sleep apnea in clinic patients undergoing diagnostic polysomnography.
    Harmon EK; Stafford P; Ibrahim S; Cho Y; Mazimba S; Bilchick K; Lin GM; Park SJ; Gharib SA; Kapur VK; Kwon Y
    J Arrhythm; 2020 Dec; 36(6):991-996. PubMed ID: 33335615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central sleep apnea on commencement of continuous positive airway pressure in patients with a primary diagnosis of obstructive sleep apnea-hypopnea.
    Lehman S; Antic NA; Thompson C; Catcheside PG; Mercer J; McEvoy RD
    J Clin Sleep Med; 2007 Aug; 3(5):462-6. PubMed ID: 17803008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting.
    Holm M; Biancari F; Khodabandeh S; Gherli R; Airaksinen J; Mariscalco G; Gatti G; Reichart D; Onorati F; De Feo M; Santarpino G; Rubino AS; Maselli D; Santini F; Nicolini F; Zanobini M; Kinnunen EM; Ruggieri VG; Perrotti A; Rosato S; Dalén M
    Ann Thorac Surg; 2019 Jun; 107(6):1690-1698. PubMed ID: 30898561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2Y12 Inhibitors in Acute Coronary Syndromes: A Real-World, Community-Based Comparison of Ischemic and Bleeding Outcomes.
    Sachdeva A; Mutyala R; Mantri N; Zhu S; McNulty E; Solomon M
    J Interv Cardiol; 2023; 2023():1147352. PubMed ID: 37251366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Effectiveness and Safety of Ticagrelor Versus Clopidogrel for Elderly Chinese Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Retrospective Cohort Study.
    Xu S; Liang Y; Chen Y; Gao H; Tan Z; Wang Q; Liu Y; Zhu B; Tao F; Wang Q; Zhao S; Yang L; Zhang Y; Wang Z; Han P; Chen Y; Zhang A; Li C; Lian K
    Drugs Aging; 2022 Sep; 39(9):695-703. PubMed ID: 35995912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Gill K; Servati N; Flahive J; Fraielli K
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):625-629. PubMed ID: 34236915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.